2026-04-23T15:23:40Z https://www.peertechzpublications.org/oai-pmh

oai:www.peertechzpublications.org:10.17352/apdt.000011 2024-04-06 PTZ.APDT:VOL6

Progress in the development of vaccines for pancreatic adenocarcinoma Mahmoud Singer Ahmed M ElsayedMohamed I Husseiny<p>Pancreatic cancer, which is regarded as the third deadliest cancer globally, poses a significant challenge because of its limited range of treatment options and high mortality rate. Currently, there is a focus on both the development of a novel concept in vaccine designing and the parallel study of the associated immune mechanisms. To further our understanding of the healthcare field, a variety of promising designs have been introduced for in-depth study. The designs were developed to include the mKRAS-specific amphiphile vaccine, which targets a specific mutation in the KRAS gene in addition to the multi-antigen targeted DNA vaccine, which aims to stimulate an immune response against multiple cancer antigens. Furthermore, later designs of vaccines were introduced based on the development of peptide-based cancer vaccines, mRNA-based vaccines, cell-based vaccines, and engineered bacterial vectors using an oral Salmonella-based vaccine. The study presents the concept on which the new vaccine is based and discusses the up-to-date immunological manifestations of these designed vaccines.&nbsp;</p> Annals of Pancreatic Disorders and Treatment - Peertechz Publications 2024-04-06 Mini Review https://doi.org/10.17352/apdt.000011 en Copyright © Mahmoud Singer et al.